Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07224191 · ClinicalTrials.gov registry record · NA

Hippocampal Oscillations During Exploration

A NA study of Epilepsy, sponsored by NYU Langone Health.

Recruiting
Registry status
NA
Development phase
56
Enrollment target
1
Study location

NCT07224191 is a NA study of Epilepsy that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 56 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07224191, a NA study of Epilepsy, is actively recruiting participants, sponsored by NYU Langone Health.

RECRUITING
Registry status
NA
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to determine how visuomotor exploration relates to hippocampal activity along its long axis. The study will investigate the neurophysiological mechanisms in the hippocampus during (1) visual exploration in surgical patients using high-resolution iEEG, and (2) ambulatory exploration in patients implanted with RNS devices.

Conditions Studied

Interventions

  • OTHER Visual Exploration
  • OTHER Ambulatory Exploration

Study Locations (1)

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2026-02-25
Est. Completion 2028-10-08
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT07224191

The ClinicalTrials.gov registry entry for NCT07224191 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (94% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Epilepsy appearing as the primary indexed condition, and to 2 interventions - of which Visual Exploration is the first listed.

NCT07224191 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT07224191 about?

NCT07224191 is a clinical study titled "Hippocampal Oscillations During Exploration". The objective of this study is to determine how visuomotor exploration relates to hippocampal activity along its long axis. The study will investigate the neurophysiological mechanisms in the hippocampus during (1) visual exploration in surgical patients using high-resolution iEEG, and (2) ambulator...

What is the current status of trial NCT07224191?

This trial is currently recruiting. It is a NA study. The enrollment target is 56 participants. The study started on 2026-02-25. Estimated completion is 2028-10-08.

What conditions does trial NCT07224191 study?

This clinical trial studies the following conditions: Epilepsy.

What interventions are being tested in trial NCT07224191?

The interventions under investigation include: Visual Exploration (OTHER), Ambulatory Exploration (OTHER).

Who is sponsoring clinical trial NCT07224191?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07224191 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Epilepsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.